| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-64 |
| filingDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba622c59078c5629f03e3d7f61af59ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d05b0206ec6741085902afaf5cfe6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06beca94603d27d4b1e8238330c70ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d73fcb874e44baf0ca077e8154b3841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d8e1c719ef7e3fed8801575b70dc35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7ef26af339475234f4b5c8049218c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a4c99eb8ccdf8f37ad90cfd2b49e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80002c0443d1ff8721e67b4c6415394b |
| publicationDate |
2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201940505-A |
| titleOfInvention |
Modified lipidated relaxin B chain peptide and its medical use |
| abstract |
The present invention relates to a biologically active single-chain relaxin peptide having the following formula (I): N ter -Ac-X 10 -EGREX 15 -VRX 18 -X 19 -IX 21 -X 22 -EGX 25 -SX 27 -X 28 -X 29 -X 30 -X 31 -X 32 -X 33 -NH 2 -C ter or a salt or solvate thereof.n n n It also relates to a pharmaceutical composition comprising at least one of the peptides of the present invention, as well as the peptide or the pharmaceutical composition for pharmaceutical use. |
| priorityDate |
2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |